Saudi Arabia SFDA registration ME0000001481SFDAA00841
Enzygnost Anti-HBs II
Saudi Arabia·Chemicals·Siemens Healthcare diagnostics products Gmbh·Annex II List AActiveProduct information
for the qualitative detection and quantitative
determination of hepatitis B
Product use
Enzyme immunoassay for the qualitative detection and quantitative determination of specific antibodies to
the hepatitis B surface antigen (HBsAg) in human serum and plasma.
The enzyme immunoassay can be processed using the ELISA processors, BEP® III System, BEP® 2000 System
or the BEP 2000 Advance® System. A non-automated processing of the test is also possible
Device classification
- Risk Class
- Annex II List A
- Product Category
- Chemicals
- Product Type
- IVD
Registration information
- Registration ID
- ME0000001481SFDAA00841
- Authorization ID
- GHTF-2016-2406
- Status
- Active
- Expire Date
- May 29, 2017
Manufacturer
- Manufacturer Name
- Siemens Healthcare diagnostics products Gmbh
Model information
- Model ID(s)
- OQNE15 and OQNE19
Product accessories
[]
About this record
Access comprehensive regulatory information for Enzygnost Anti-HBs II in the Saudi Arabia medical device market through Pure Global AI's free database. This Annex II List A device is registered with Saudi Arabia SFDA under registration number ME0000001481SFDAA00841 and manufactured by Siemens Healthcare diagnostics products Gmbh.
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
Free DatabasePowered by Pure Global AISFDA Official DataAnnex II List A